respond on a manipulandum to obtain reinforcement only after a criterion time has elapsed since the onset of a signal (Catania, 1970; Gibbon, 1991; Roberts, 1981) . A measure of when the animal anticipates the reinforcer can be obtained on "peak" trials in which reward is withheld and the signal is extended beyond the criterion time. After some exposure to this procedure, response rates on peak trials increase and reach a maximum around the expected time of reward and decrease thereafter. Shifts in this temporal gradient can be used to track changes in the expected time of reward. For example, if a drug slows the speed of the internal clock, then the response distribution will immediately shift to the right following drug administration. In a recent study in which ring doves were trained on a Pavlovian analogue of the peak interval procedure (Bitterman, 1964; Ohyama, Gibbon, Deich, & Balsam, 1999) , we found that pimozide, a DA receptor antagonist, produced a gradual shift to the right rather than an immediate change in the temporal distribution of conditioned keypecking (Ohyama, Horvitz, Kitsos, & Balsam, 2000) . One interpretation of a gradual change is that DA distorts memories of the expected time of reward as they are stored (Meek, 1983 (Meek, , 1996 . The shift in the gradient is gradual because repeated reinforced trials are necessary to establish a distribution of distorted memories dense enough to consistently influence time estimation. An alternative account of the gradual shift, however, is that repeated pairings of cues associated with the injection procedure and the unconditioned effects of pimozide gradually establish a conditioned response (CR) that influences timing. The present study sought to test whether repeated injections of pimozide affect time estimation by changing clock speed, distorting memories for time intervals, or by establishing a CR to injection-related conditioned stimuli (CS).
Eighteen rats were trained on the peak procedure with a tone as the signal and a criterion time of 15 s, and after stable temporal discriminations were established they were divided into three matched groups. During the 7 subsequent treatment days, each group received injections of either the DA antagonist pimozide or vehicle solution, before or after each training session. Group PRE-VEH received injections of the DA antagonist pimozide before, group POST-VEH received injections of pimozide in the home cage after, and group VEH-VEH received injections of vehicle solution before each daily session. On the final 2 days, all groups received extinction sessions consisting only of peak trials, with vehicle injections before each test session. If pimozide slows the speed of a pacemaker by blocking DA transmission, the expected time of reward should be reached later during sessions in which the drug is present than during baseline sessions, because the threshold for responding should be reached later than normal.
In this case, the only change in timing should occur in group PRE-VEH during the treatment phase. This shift in peak time should occur immediately once the drug is administered and shift back immediately in the absence of the drug during extinction. In all other groups, timing should be unaffected because pimozide is not present during the treatment or extinction sessions. Alternatively, if pimozide distorts memories for the time of reward as they are stored, group PRE-VEH should exhibit a gradual shift in peak time during the treatment phase, and these distorted times stored under the influence of the drug should persist in the extinction test. and CR hypotheses predict a sustained shift for group PRE-VEH, whereas only the CR hypothesis predicts a shift for group POST-VEH.
Method

Subjects
Eighteen albino rats, obtained from Charles River (Kinsington, NY), served as the subjects. The rats were housed in individual cages. At the start of the experiment, the rats were at least 2 months old. During the period in which they received training on the peak procedure, the rats were kept at 80-85% of their free-feeding weights. The rats were fed their normal ration of rat chow (Purina 5012 Rat Diet, Ralston-Purina, St. Louis, MO) within 1 hr after the experimental session.
Apparatus
Six identical Coulbourn chambers (Coulboum Instruments, Allentown, PA) were used in the experiment. The dimensions of a chamber were 25 X 29 X 29 cm. The floor of the chamber consisted of 16 stainless steel rods spaced 18 mm apart. A food aperture (3X4 cm) was situated at the bottom-center of the front wall panel. The houselight was located near the top of the front wall panel. Each chamber was equipped with a seven-tone generator (El 2-07; Coulbourn Instruments), an automatic food dispenser, and a response lever situated at the right of the food aperture, 6.5 cm from the floor. A photocell positioned in the food aperture recorded head entries.
The chambers were enclosed in soundproof boxes constructed of wood and insulation material (inner dimensions, 70 X 50 X 50 cm). The boxes were equipped with electrical fans that masked external noise. A Dell Pentium PC was situated in the same room and served to control stimulus presentation and record data with the L2T2 operant control system software (Version 4.00).
Procedure
During pretraining, subjects were first trained to press the lever by presentation of food on a continuous reinforcement schedule. Each session began with the houselight turned on, and each press of the lever was followed by presentation of one 45-mg food pellet (Bioserve, Frenchtown, NJ) by activation of the pellet dispenser. Sessions ended after 60 reinforcements were delivered or 2 hr had elapsed. Training continued until 60 responses were completed within 30 min for 2 consecutive days. During the next phase, subjects were presented with 20 fixed-interval (FI) trials in which a lOOO-H?, tone (72 dB) sounded and the first lever press after 15 s from the onset of the tone terminated it and activated the pellet dispenser.
This series was followed by 10 FI trials randomly intermixed with 10 unreinforced peak trials, in which the tone sounded and remained on for 45 s plus a variable delay (geometrically distributed with a minimum of 5 s and a mean of 15 s). During subsequent baseline training, subjects were presented with 20 FI trials and 20 peak trials in each session. No more than 4 trials of the same type occurred consecutively. Subjects were trained once a day, 5 days per week, for a total of at least 50 sessions, until temporal discriminations were clearly established by visual inspection of peak trial data collapsed across the last four sessions. (The discrimination ratio, an index of the degree of temporal discrimination calculated by dividing the maximum rate in the peak trial by the overall response rate during the peak trials on the basis of the responses up to 45 s, was also used to establish that performance was highly stable during these sessions.) For the last 30 baseline sessions and all subsequent sessions of the experiment, the intertrial interval was fixed at 120 s.
Three groups of rats were matched with respect to their maximum response rates and peak times during the last 4 days of baseline training.
During the treatment phase, group PRE-VEH received 0.6 mg/kg pimozide 30 min before each training session. Group VEH-VEH received an injection of the lactic acid vehicle 30 min before each session. Group POST-VEH received 0.6 mg/kg pimozide 1 hr postsession. This phase lasted for 7 consecutive days. Pimozide (Research Biochemical International, Natick, MA) was dissolved in 0.2% lactic acid, rntraperitoneal injections of the drug were delivered in a volume of 1 ml/kg body weight.
The dose (0.6 mg/kg) was chosen on the basis of previous experiments using the temporal bisection procedure (Meek, 1986) .
Immediately following the treatment phase, all subjects were tested on 2 successive days of extinction. During each extinction session, 40 peak trials were presented without reinforcement. All subjects were given intraperitoneal injections of the vehicle solution 30 min before each extinction session.
Peak time, a measure of the expected time of reinforcement, was calculated as follows: Average response rates during each second of the unreinforced peak trials were first obtained for each phase of the experiment (baseline, treatment, or extinction) and for each block of 20 peak trials for each subject (during baseline and treatment phases this was a daily average, whereas during extinction it was an average for half of the session). Peak time was then calculated on the basis of the responses occurring within the first 45 s of the peak trial and was defined as the midpoint of the interquartile range. The maximum rate, which generally occurred around the expected time of reinforcement, was used in all of the response rate analyses presented in this article.
Results
Peak time changed clearly as a function of experimental phase and group. In group PRE-VEH, peak time increased during the treatment phase and the increase was sustained in extinction. A repeated measures (RM) one-way analysis of variance (ANOVA) on absolute peak times averaged across each phase revealed a significant effect of phase, F(2, 10) = 18.41, p < .01. Pairedcomparison t tests revealed that peak time was both greater during treatment than baseline, r(5) = 4.2, p < .01, and greater during extinction than baseline, 1(5) = 4.83, p < .01. As expected, there was no change in peak time for group VEH-VEH. An RM one-way ANOVA on absolute peak time failed to reveal an effect of phase, F(2, 10) < 1. The results for the crucial group POST-VEH were clear-cut: Peak time did not change during the treatment phase but increased in extinction. An RM one-way ANOVA on absolute peak times revealed a significant effect of phase, F(2, 10) = 14.87, p < .01. Paired-comparison t tests revealed that peak time did not differ between baseline and treatment, r(5) < 1, but was greater in extinction than either baseline or treatment, r(5) = 3.44, p < .05 and ((5) = 5.74, p < .01, respectively. Figure 1 shows peak time plotted as a proportion of the average on the last 3 baseline days in blocks of 20 peak trials. During the treatment phase, peak time as a proportion of baseline increased gradually for group PRE-VEH but remained unchanged for POST-VEH and VEH-VEH. An RM two-way ANOVA with trial block and group as within-and between-subject factors revealed a significant effect of block, F(2, 13) = 11.71, p < .01, as well as Group X Block interaction, F(12, 78) = 2.23, p < .05. Independent one-way ANOVAs at each block revealed that peak time did not differ among groups in Blocks 1 and 2 (Fs < 3) but differed in Blocks 3 through 6 (Fs > 5, ps < .05) and marginally in revealed significant differences between PRE-VEH and POST-VEH in Blocks 3 to 6 and between PRE-VEH and VEH-VEH in Blocks 4 to 6. Figure 2 shows the maximum rate of responding plotted as a proportion of the average of the last 3 baseline days. During the treatment phase, response rate as a proportion of baseline decreased immediately in group PRE-VEH but remained elevated in POST-VEH and VEH-VEH. An RM two-way ANOVA with trial block and group as within-and between-subject factors revealed a significant effect of block, F(2, 13) = 13.51, p < .01, but no Group X Block interaction, F(12, 78) < 1.7. During extinction, response rate declined in all groups. An RM one-way ANOVA revealed a significant effect of block, F(3, 42) = 27.04, p < .01. The rate of decline did not differ among groups. An RM two-way ANOVA revealed neither a significant group effect, F(2, 14) < 1, nor Group X Block interaction, F(6, 42) = 1.34.
Discussion
Peak time increased only for group PRE-VEH during the treatment phase, and this increase occurred gradually. During extinction this increase was sustained, and an increase was also seen for group POST-VEH (see Figure 1 ). This pattern of results supports the CR hypothesis and is inconsistent with the hypotheses that pimozide directly changes pacemaker rates or distorts memory storage of time intervals. In contrast to the gradual change in timing, pimozide produced an immediate decline in the maximum rate of responding in group PRE-VEH during the treatment phase, consistent with previous literature on the effects of neuroleptics on appetitive responding (Wise, 1982) . The dissociation between peak time and maximum response rate suggests that the underlying mechanisms mediating each are independent. Further support for this view comes from the extinction data. Although peak times clearly differed across the three groups, there was no difference in response rates during the extinction phase (see right panels of Figures 1 and 2) . The overall pattern of results suggests that the immediate effect of pimozide on response rate is mediated by the unconditioned reaction (UR) to drug, whereas its effect on peak time is mediated by a CR. The drug itself modulates response rates, and the CSs associated with the drug modulate response timing.
Note that response rates in group PRE-VEH recovered completely during extinction. If reinforced training under pimozide mimicked extinction (Wise, 1982) , some generalized extinction during the test should have occurred. However, extinction is context dependent (Bouton, 1993) and the switch from drug to nondrug conditions may have provided enough of a context change for the complete recovery.
Two other points are worth noting. The first is that the UR and CR did not produce similar effects on behavior. In the present study, pimozide produced an unconditioned suppression of response rate (UR) and the CSs associated with the drug produced the change in timing (CR). That the UR and CR have different behavioral manifestations is a common finding in Pavlovian conditioning, even at the behavioral level. For example, pigeons will exhibit increased general activity in response to a tone or context paired with food, even though the UR to food is pecking (Longo, Klempay, & Bitterman, 1964; Mustaca, Gabelli, Papini, & Balsam, 1991) . In drug tolerance, the initial unconditioned analgesic effects of a drug such as morphine (UR) are attenuated by the gradual development of a conditioned response (CR) to CSs associated with the drug (Siegel, 1976) . The second point concerns the nature of the CR. Our data suggest that the behavioral CR (i.e., a rightward shift in timing) is induced either by a slowing of a pacemaker or a distortion in memory retrieval. At the physiological level, such effects may have been mediated by conditioned decreases in striatal DA activity (Besson & Louilot, 1995 Mark, Blander, & Hoebel, 1991) . If this were the case, the conditioned decrease in DA might also have suppressed responding during the extinction test in the groups that showed the shift in timing (PRE-VEH and POST-VEH), to the extent that a decrease in DA transmission also mediated the initial suppressive effect of pimozide. However, neither group showed response suppression in the absence of the pimozide (see right panel of Figure 2 ). This implies that other responses not directly related to DA may have mediated the shift in timing. There is precedent for drugs that modulate DA to produce CRs that are not DA dependent. Beninger and Hahn (1983) have shown that the unconditioned increase in activity produced by amphetamine is DA dependent, whereas the conditioned hyperactivity produced by CSs associated with amphetamine is not. Therefore, it seems likely that DA itself is not directly mediating the change in timing. The results are compatible with the interesting hypothesis that separate aspects of behavior may be controlled by the mesolimbic and nigrostriatal pathways (Robbins & Everitt, 1992) , the former implicated in reward-related processes and the latter commonly thought to be involved in motor processes or stimulus-response habits. The response-suppressing effects of pimozide may be mediated by its relatively immediate impact within the mesolimbic pathway (Wise, 1982) , whereas the effects on timing may be mediated by slower, indirect experiencedependent changes induced by action of pimozide in the nigroslriatal pathway (Meek, 1996) . An important implication of the results is that the effects of dopaminergic drugs on cognitive and behavioral function may be due not only to the unconditioned effects of a drug but also to CRs that become associated with the administration of that drug. Antipsychotics typically produce an immediate sedative effect (UR) and a delayed therapeutic action (Crow, Johnstone, Longden, & Owen, 1978; Levy, 1996) . In the past, researchers have emphasized changes in receptor sensitivity (Florijn, Tarazi, & Creese, 1997; Lidow, Williams, & Goldman-Rakic, 1998) , depolarization block of midbrain DA neurons (Bunney, 1988; Grace, 1992) , or drug accumulation (Kornhuber, Retz, & Riederer, 1995) as possible bases for the finding that schizophrenic patients must take DA antagonist drugs for several weeks before experiencing an alleviation of symptoms. The present study raises the important possibility that the delayed therapeutic effects of antipsychotic drugs may be mediated by a Pavlovian conditioning process. Perhaps the therapeutic effects are evoked only after the occurrence of sufficient pairings of the drug with cues associated with its administration. More generally, our findings may be of great practical importance beyond their application to the delayed onset of effectiveness of antipsychotic drugs. Many of the clinically useful effects of drugs do not emerge until the drugs have been experienced multiple times (Kornhuber et al., 1995) . This raises the important possibility that drug effects are, in general, some combination of effects caused by direct pharmacological actions of the drug itself, drug accumulation, slower structural changes induced by drug action, and conditioned responses that develop to the stimuli associated with drug administration.
